Unosi

• Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study (2019-02)

  A. Verhaz, Z. Kezić, R. Škrbić, M. Stoiljković, Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study, STED Journal, Vol. 50, No. 3, pp. 77 - 81, Feb, 2019